Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10552-020-01270-8.pdf
Reference32 articles.
1. Capitanio U, Montorsi F (2016) Seminar renal cancer. Lancet. https://doi.org/10.1016/S0140-6736(15)00046-X
2. Vaishampayan UN, Do H, Hussain M, Schwartz K (2003) Racial disparity in incidence patterns and outcome of kidney cancer. Urology 62:1012–1017. https://doi.org/10.1016/j.urology.2003.07.010
3. Stafford HS, Saltzstein SL, Shimasaki S et al (2008) Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival. J Urol 179:1704–1708. https://doi.org/10.1016/j.juro.2008.01.027
4. Chow W-H, Shuch B, Linehan WM, Devesa SS (2012) Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer 119:388–394. https://doi.org/10.1002/cncr.27690
5. Schwartz K, Ruterbusch JJ, Colt JS et al (2016) Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors. Cancer Med 5:200–208. https://doi.org/10.1002/cam4.578
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeted Literature Review of Outcomes to Initial Systemic Therapy for Advanced/Metastatic Non-Clear Cell Renal Cell Carcinoma in Observational Studies;Kidney Cancer;2023-10-10
2. Development and External Validation of Machine Learning-Based Models for Predicting Lung Metastasis in Kidney Cancer: A Large Population-Based Study;International Journal of Clinical Practice;2023-06-20
3. African American vs Caucasian race/ethnicity in adrenocortical carcinoma patients;Endocrine-Related Cancer;2023-04-12
4. Differences in overall survival between clear cell metastatic renal cell carcinoma patients versus population-based controls according to race/ethnicity in the United States;Annals of Epidemiology;2023-03
5. Other-cause mortality and access to care in metastatic renal cell carcinoma according to race/ethnicity;Urologic Oncology: Seminars and Original Investigations;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3